Advanced proteomics and AI reveal blood protein changes, offering insights into early Alzheimer's detection and differentiation from mild cognitive impairment.
A major limitation to the discovery of new therapeutics and unique biomarkers of disease is the ability to identify, purify, and characterize valuable trace proteins in the presence of highly abundant ...
Protein detection sensitivity has historically lagged behind nucleic acid detection by 2-3 orders of magnitude due to the lack of intrinsic signal amplification. While digital methods such as Single ...
Explore how proteomics enhances infectious disease detection, pathogen identification, and host response profiling in ...
Treatment of neurodegenerative diseases faces a significant challenge due to the lack of effective diagnostic methods for early detection and monitoring of disease progression. Protein misfolding, a ...
MiROM identifies proteins by using mid-infrared light to detect molecular vibrations – essentially the natural "dance" of molecules within protein structures. Unlike optical spectroscopy, which ...
As the demands for more detailed protein characterization increase, many companies are working to meet those demands through new tools, technologies, and assays. Alistair Kippen, Ph.D., head of ...
Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.
Expression proteomics determines where and when proteins are expressed and measures their quantities. This qualitative and quantitative approach can compare protein expression across conditions, such ...
Spread the loveIn a groundbreaking study published on March 14, 2026, scientists from Durham University unveiled a fascinating discovery that could transform the landscape of rapid diagnostic testing ...